Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ependymoma × Radiation × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 15 Esophageal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Rectal Neoplasms 6 Oropharyngeal Neoplasms 6 Glioma 6 Breast Neoplasms 6 Mouth Neoplasms 5 Glioblastoma 5 Pancreatic Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Multiple Myeloma 3 Laryngeal Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Medulloblastoma 2 Hypopharyngeal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1

Interventions

Temozolomide 2 ONC206 2 Etoposide 2 Cyclophosphamide 2 lutetium Lu 177 dotatate 1 ibrutinib 1 fenofibric acid 1 etoposide phosphate 1 Thalidomide 1 Restraint, Physical 1 Radiotherapy 1 Radiation 1 Magnetic Resonance Spectroscopy 1 Linear Energy Transfer 1 Irinotecan 1 Elasticity Imaging Techniques 1 Cytarabine 1 Celecoxib 1 Bevacizumab 1 Automobiles 1 1-methyltryptophan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04732065 2026-03-17

PNOC023

University of California, San Francisco

Phase 1 Recruiting

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡